Book contents
- Treatment of Dystonia
- Treatment of Dystonia
- Copyright page
- Contents
- Contributors
- Preface
- 1 Development of the Concept of Dystonia as a Disease, a Syndrome and a Movement Phenomenology
- Section I Basics
- Section II Botulinum Toxin Therapy
- 21 The Global Market for Botulinum Toxin
- 22 Molecular Mechanisms of Botulinum Toxin
- 23 Indirect Central Nervous System Effects of Botulinum Toxin
- 24 Direct Central Nervous System Effects of Botulinum Neurotoxin
- 25 Analgesic Effects of Botulinum Toxins
- 26 Manufacture of Commercial Botulinum Neurotoxins for Human Treatment
- 27 Pharmacology of Botulinum Toxins
- 28 Immunology of Botulinum Toxin Therapy
- 29 Use of Non-A/Non-B Botulinum Toxins
- 30 Clinical Muscular Anatomy for the Botulinum Toxin Injector
- 31 Ultrasound Guidance for Botulinum Toxin Application
- 32 Treatment Algorithms and Injection Schemes for Botulinum Toxin Therapy of Dystonia
- 33 Botulinum Toxin Therapy for Cervical Dystonia
- 34 Botulinum Toxin Therapy for Cranial Dystonia
- 35 Botulinum Toxin Therapy for Spasmodic Dysphonia
- 36 Botulinum Toxin Therapy for Writer’s Cramp and Other Focal Hand Dystonias
- 37 Botulinum Toxin Therapy for Bruxism
- 38 Treatment of Blepharospasm With Eyelid-Opening Apraxia
- 39 Organisation of a Botulinum Toxin Clinic
- Section III Musician’s Dystonia
- Section IV Psychogenic Dystonia
- Section V Treatment of Paediatric Dystonia
- Section VI Rehabilitation of Dystonia
- Section VII Pharmacotherapy for Dystonia
- Section VIII Surgical Treatment of Dystonia
- Section IX Deep Brain Stimulation for Dystonia
- Section X Emerging Therapies for Dystonia
- Section XI Future Trends in Dystonia Therapy
- Book part
- Index
- References
36 - Botulinum Toxin Therapy for Writer’s Cramp and Other Focal Hand Dystonias
from Section II - Botulinum Toxin Therapy
Published online by Cambridge University Press: 31 May 2018
Book contents
- Treatment of Dystonia
- Treatment of Dystonia
- Copyright page
- Contents
- Contributors
- Preface
- 1 Development of the Concept of Dystonia as a Disease, a Syndrome and a Movement Phenomenology
- Section I Basics
- Section II Botulinum Toxin Therapy
- 21 The Global Market for Botulinum Toxin
- 22 Molecular Mechanisms of Botulinum Toxin
- 23 Indirect Central Nervous System Effects of Botulinum Toxin
- 24 Direct Central Nervous System Effects of Botulinum Neurotoxin
- 25 Analgesic Effects of Botulinum Toxins
- 26 Manufacture of Commercial Botulinum Neurotoxins for Human Treatment
- 27 Pharmacology of Botulinum Toxins
- 28 Immunology of Botulinum Toxin Therapy
- 29 Use of Non-A/Non-B Botulinum Toxins
- 30 Clinical Muscular Anatomy for the Botulinum Toxin Injector
- 31 Ultrasound Guidance for Botulinum Toxin Application
- 32 Treatment Algorithms and Injection Schemes for Botulinum Toxin Therapy of Dystonia
- 33 Botulinum Toxin Therapy for Cervical Dystonia
- 34 Botulinum Toxin Therapy for Cranial Dystonia
- 35 Botulinum Toxin Therapy for Spasmodic Dysphonia
- 36 Botulinum Toxin Therapy for Writer’s Cramp and Other Focal Hand Dystonias
- 37 Botulinum Toxin Therapy for Bruxism
- 38 Treatment of Blepharospasm With Eyelid-Opening Apraxia
- 39 Organisation of a Botulinum Toxin Clinic
- Section III Musician’s Dystonia
- Section IV Psychogenic Dystonia
- Section V Treatment of Paediatric Dystonia
- Section VI Rehabilitation of Dystonia
- Section VII Pharmacotherapy for Dystonia
- Section VIII Surgical Treatment of Dystonia
- Section IX Deep Brain Stimulation for Dystonia
- Section X Emerging Therapies for Dystonia
- Section XI Future Trends in Dystonia Therapy
- Book part
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Treatment of Dystonia , pp. 178 - 181Publisher: Cambridge University PressPrint publication year: 2018
References
Asahi, T, Koh, M, Kashiwazaki, D, Kuroda, S. 2014. Stereotactic neurosurgery for writer’s cramp: report of two cases with an overview of the literature. Stereotact Funct Neurosurg 92:405–411.CrossRefGoogle ScholarPubMed
Cohen, LG, Hallett, M. 1988. Hand cramps: clinical features and electromyographic patterns in a focal dystonia. Neurology 38:1005–1012.CrossRefGoogle Scholar
Epidemiological Study of Dystonia in Europe Collaborative Group. 2000. A prevalence study of primary dystonia in eight European countries. J Neurol 247:787–792.CrossRefGoogle Scholar
Grigoriu, AI, Dinomais, M, Remy-Neris, O, Brochard, S. 2015. Impact of injection-guiding techniques on the effectiveness of botulinum toxin for the treatment of focal spasticity and dystonia: a systematic review. Arch Phys Med Rehabil 96:2067–2078.CrossRefGoogle ScholarPubMed
Hallett, M, Albanese, A, Dressler, D, Segal, KR, Simpson, DM, Truong, D, Jankovic, J. 2013. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. Toxicon 67:94–114.CrossRefGoogle ScholarPubMed
Jankovic, J, Van der Linden, C. 1988. Dystonia and tremor induced by peripheral trauma: predisposing factors. J Neurol Neurosurg Psychiatry 51:1512–1519.CrossRefGoogle ScholarPubMed
Jost, W, Valerius, K-P 2008. Pictorial Atlas of Botulinum Toxin Injection: Dosage, Localization, Application. Berlin: KVM.Google Scholar
Karp, BI. 2012. Botulinum toxin physiology in focal hand and cranial dystonia. Toxins 4:1404–1414.CrossRefGoogle ScholarPubMed
Karp, BI, Cole, RA, Cohen, LG, Grill, S, Lou, JS, Hallett, M. 1994. Long-term botulinum toxin treatment of focal hand dystonia. Neurology 44:70–76.CrossRefGoogle ScholarPubMed
Kruisdijk, JJ, Koelman, JH, Ongerboer de Visser, BW, de Haan, RJ, Speelman, JD. 2007. Botulinum toxin for writer’s cramp: a randomised, placebo-controlled trial and 1-year follow-up. J Neurol Neurosurg Psychiatry 78:264–270.CrossRefGoogle ScholarPubMed
Lungu, C, Karp, BI, Alter, K, Zolbrod, R, Hallett, M. 2011. Long-term follow-up of botulinum toxin therapy for focal hand dystonia: outcome at 10 years or more. Mov Disord 26:750–753.Google Scholar
Molloy, FM, Shill, HA, Kaelin-Lang, A, Karp, BI. 2002. Accuracy of muscle localization without EMG: implications for treatment of limb dystonia. Neurology 58:805–807.CrossRefGoogle ScholarPubMed
Nibbeling, E, Schaake, S, Tijssen, MA, Weissbach, A, Groen, JL, Altenmüller, E, Verbeek, DS, Lohmann, K. 2015. Accumulation of rare variants in the arylsulfatase G (ARSG) gene in task-specific dystonia. J Neurol 262:1340–1343.Google Scholar
Nutt, JG, Muenter, MD, Melton, LJ, 3rd, Aronson, A, Kurland, LT. 1988. Epidemiology of dystonia in Rochester, Minnesota. Adv Neurol 50:361–365.Google ScholarPubMed
Sheehy, MP, Marsden, CD. 1982. Writers’ cramp: a focal dystonia. Brain 105 (Pt 3):461–480.CrossRefGoogle ScholarPubMed
Simpson, DM, Blitzer, A, Brashear, A, Comella, C, Dubinsky, R, Hallett, M, Jankovic, J, Karp, B, Ludlow, CL, Miyasaki, JM, Naumann, M, So, Y. 2008. Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 70:1699–1706.CrossRefGoogle Scholar
Truong, D, Hallett, M, Zachary, C, Dressler, D (Eds). 2014. Manual of Botulinum Toxin Therapy, 2nd edn. Cambridge: Cambridge University Press.CrossRefGoogle Scholar
Wissel, J, Kabus, C, Wenzel, R, Klepsch, S, Schwarz, U, Nebe, A, Schelosky, L, Scholz, U, Poewe, W. 1996. Botulinum toxin in writer’s cramp: objective response evaluation in 31 patients. J Neurol Neurosurg Psychiatry 61:172–175.CrossRefGoogle ScholarPubMed
Yoshimura, DM, Aminoff, MJ, Olney, RK. 1992. Botulinum toxin therapy for limb dystonias. Neurology 42:627–630.CrossRefGoogle ScholarPubMed